share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.

Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%)等

SEC announcement ·  02/14 17:49
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息